{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:07:05Z","timestamp":1793210825456,"version":"4.5.0"},"reference-count":200,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Autoimmune diseases (ADs) are strongly associated with a significantly increased risk of lymphoma, with the standardised incidence ratio (SIR) markedly elevated in certain conditions, most notably in Sj\u00f6gren\u2019s disease (SjD) where an SIR as high as 18.8 has been reported. The risk is particularly prominent for diffuse large B-cell lymphoma (DLBCL) and mucosa-associated lymphoid tissue (MALT) lymphoma. This review systematically elucidates the epidemiological features, pathological mechanisms, risk factors, and therapeutic strategies of ADs-associated lymphomas. Epidemiological studies have confirmed strong associations between ADs such as rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and SjD with specific lymphoma subtypes, and these associations appear to be bidirectional. Core pathogenic mechanisms involve malignant transformation driven by the immune\u2013inflammatory continuum: chronic antigenic stimulation and the inflammatory microenvironment result in regulatory cell (Treg\/Breg) dysfunction, tertiary lymphoid structure (TLS) formation, and clonal evolution. Specific autoantibodies directly contribute to oncogenesis by interfering with intracellular signalling pathways, mimicking antigenic stimulation, and forming immune complexes, while infectious agents such as Epstein\u2013Barr virus synergistically promote malignant transformation within immunosuppressive microenvironments. Risk factors encompass intrinsic disease features, treatment-related risks and gene\u2013environment interactions. Clinical management must balance the dual imperatives of \u201ccontrolling inflammation\u201d and \u201cminimising treatment-related risks\u201d. Targeted therapies, such as rituximab and BTK inhibitors, as well as haematopoietic stem cell transplantation (HSCT), have offered hope, but prognosis remains profoundly influenced by baseline immune status. Future research should focus on risk stratification guided by multi-omics, the application of novel immunotherapies in the autoimmune setting, and the optimisation of multidisciplinary care models.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1719391","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T06:45:29Z","timestamp":1767681929000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Autoimmune disease-associated lymphomas: research progress and review"],"prefix":"10.3389","volume":"16","author":[{"given":"Chengqian","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangzhi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingtong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoxia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haotian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ou","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2015.09.001","article-title":"A molecular perspective on rituximab: A monoclonal antibody for B cell non hodgkin lymphoma and other affections","volume":"97","author":"Seyfizadeh","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41408-018-0105-4","article-title":"History of autoimmune conditions and lymphoma prognosis","volume":"8","author":"Kleinstern","year":"2018","journal-title":"Blood Cancer J"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V27.4.435.435","article-title":"Autoimmune disease in nzb-bl mice. Ii. Autoimmunity and Malignant lymphoma","volume":"27","author":"Mellors","year":"1966","journal-title":"Blood"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1080\/0284186x.2019.1619936","article-title":"Autoimmune disease in patients with diffuse large B-cell lymphoma: occurrence and impact on outcome","volume":"58","author":"M\u00f6rth","year":"2019","journal-title":"Acta Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-020-03583-9","article-title":"Autoimmune disease-related primary cns lymphoma: systematic review and meta-analysis","volume":"149","author":"Kaulen","year":"2020","journal-title":"J Neurooncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2017.11.009","article-title":"Characterizing autoimmune disease-associated diffuse large B-cell lymphoma in a seer-medicare cohort","volume":"18","author":"Koff","year":"2018","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"B7","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1186\/s12885-025-13754-4","article-title":"Autoimmune disease and risk of lymphoma: analysis from real-world data and mendelian randomization study","volume":"25","author":"Zhan","year":"2025","journal-title":"BMC Cancer"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2498","article-title":"Presence of autoimmune disease affects not only risk but also survival in patients with B-cell non-hodgkin lymphoma","volume":"36","author":"Kleinstern","year":"2018","journal-title":"Hematol Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.12283","article-title":"The five major autoimmune diseases increase the risk of cancer: epidemiological data from a large-scale cohort study in China","volume":"42","author":"Zhou","year":"2022","journal-title":"Cancer Commun (Lond)"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2021.102647","article-title":"Population-based study on the association between autoimmune disease and lymphoma: national health insurance service-national sample cohort 2002\u20132015 in korea","volume":"121","author":"Kim","year":"2021","journal-title":"J Autoimmun"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-024-05805-w","article-title":"Risk factors for non-hodgkin\u2019s lymphoma in autoimmune disease: A large database analysis","volume":"103","author":"Chennapragada","year":"2024","journal-title":"Ann Hematol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"29163","DOI":"10.1038\/s41598-024-79791-4","article-title":"Mendelian randomization analysis reveals causal effects of inflammatory bowel disease and autoimmune hyperthyroidism on diffuse large B-cell lymphoma risk","volume":"14","author":"Lyu","year":"2024","journal-title":"Sci Rep"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2021.5680","article-title":"Immune-mediated diseases associated with cancer risks","volume":"8","author":"He","year":"2022","journal-title":"JAMA Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2023.103442","article-title":"Autoimmune lymphoproliferative syndrome: A disorder of immune dysregulation","volume":"22","author":"Paskiewicz","year":"2023","journal-title":"Autoimmun Rev"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-020-03488-w","article-title":"Regulation of B-cell function by nf-kappab C-rel in health and disease","volume":"77","author":"Basavarajappa","year":"2020","journal-title":"Cell Mol Life Sci"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2006.06.002","article-title":"Targeting baff: immunomodulation for autoimmune diseases and lymphomas","volume":"112","author":"Sutherland","year":"2006","journal-title":"Pharmacol Ther"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2020.102945","article-title":"Lymphoma in the setting of autoimmune diseases: A review of association and mechanisms","volume":"150","author":"Khanmohammadi","year":"2020","journal-title":"Crit Rev Oncol Hematol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ygeno.2011.03.007","article-title":"A search for overlapping genetic susceptibility loci between non-hodgkin lymphoma and autoimmune diseases","volume":"98","author":"Conde","year":"2011","journal-title":"Genomics"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2011.08624.x","article-title":"Tnfaip3 abnormalities in malt lymphoma with autoimmunity","volume":"154","author":"Chanudet","year":"2011","journal-title":"Br J Haematol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102882","article-title":"Autoimmunity and cancer","volume":"20","author":"Masetti","year":"2021","journal-title":"Autoimmun Rev"},{"key":"B21","doi-asserted-by":"publisher","first-page":"3403","DOI":"10.3390\/jcm9113403","article-title":"The\u00a0role of autoimmune diseases in the prognosis of lymphoma","volume":"9","author":"Masciopinto","year":"2020","journal-title":"J Clin Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2016.1180972","article-title":"B cells gone rogue: the intersection of diffuse large B cell lymphoma and autoimmune disease","volume":"9","author":"Koff","year":"2016","journal-title":"Expert Rev Hematol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.semcancer.2019.06.001","article-title":"Antibody therapeutics and immunoregulation in cancer and autoimmune disease","volume":"64","author":"Yasunaga","year":"2020","journal-title":"Semin Cancer Biol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.27944","article-title":"Lifestyle factors, autoimmune disease and family history in prognosis of non-hodgkin lymphoma overall and subtypes","volume":"132","author":"Simard","year":"2013","journal-title":"Int J Cancer"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e515","DOI":"10.1038\/bcj.2016.123","article-title":"Familial associations of lymphoma and myeloma with autoimmune diseases","volume":"7","author":"Hemminki","year":"2017","journal-title":"Blood Cancer J"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu365","article-title":"Autoimmune diseases associated with non-hodgkin lymphoma: A nationwide cohort study","volume":"25","author":"Fallah","year":"2014","journal-title":"Ann Oncol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e000184","DOI":"10.1136\/bmjmed-2022-000184","article-title":"Environmental risk factors for non-hodgkin\u2019s lymphoma: umbrella review and comparison of meta-analyses of summary and individual participant data","volume":"1","author":"Shi","year":"2022","journal-title":"BMJ Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.140533","article-title":"Incidence of Malignancy and the risk of lymphoma in Japanese patients with rheumatoid arthritis compared to the general population","volume":"42","author":"Hashimoto","year":"2015","journal-title":"J Rheumatol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.860794","article-title":"Association between systemic lupus erythematosus and cancer morbidity and mortality: findings from cohort studies","volume":"12","author":"Zhang","year":"2022","journal-title":"Front Oncol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203305","article-title":"Primary sjogren\u2019s syndrome and Malignancy risk: A systematic review and meta-analysis","volume":"73","author":"Liang","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"B31","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1001\/2012.jama.10857","article-title":"Risk of Malignancies in patients with rheumatoid arthritis treated with biologic therapy: A meta-analysis","volume":"308","author":"Lopez-Olivo","year":"2012","journal-title":"Jama"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kes350","article-title":"Risk of cancer in patients receiving non-biologic disease-modifying therapy for rheumatoid arthritis compared with the uk general population","volume":"52","author":"Mercer","year":"2013","journal-title":"Rheumatol (Oxford)"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa330","article-title":"Lymphoma risks in patients with rheumatoid arthritis treated with biological drugs-a swedish cohort study of risks by time, drug and lymphoma subtype","volume":"60","author":"Hellgren","year":"2021","journal-title":"Rheumatol (Oxford)"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2018.11.004","article-title":"Systemic lupus erythematosus and lymphoma: incidence, pathogenesis and biology","volume":"75","author":"Klein","year":"2018","journal-title":"Leuk Res"},{"key":"B35","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1186\/s13075-018-1760-3","article-title":"The risks of cancer development in systemic lupus erythematosus (Sle) patients: A systematic review and meta-analysis","volume":"20","author":"Song","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez011","article-title":"Bidirectional relationship between systemic lupus erythematosus and non-hodgkin\u2019s lymphoma: A nationwide population-based study","volume":"58","author":"Wang","year":"2019","journal-title":"Rheumatol (Oxford)"},{"key":"B37","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13045-017-0464-5","article-title":"Characterization and risk estimate of cancer in patients with primary sj\u00f6gren syndrome","volume":"10","author":"Brito-Zer\u00f3n","year":"2017","journal-title":"J Hematol Oncol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-10-119974","article-title":"Autoimmune disorders and risk of non-hodgkin lymphoma subtypes: A pooled analysis within the interlymph consortium","volume":"111","author":"Ekstr\u00f6m Smedby","year":"2008","journal-title":"Blood"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2019.102317","article-title":"Genetic contributors and soluble mediators in prediction of autoimmune comorbidity","volume":"104","author":"Nezos","year":"2019","journal-title":"J Autoimmun"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.165.20.2337","article-title":"The risk of lymphoma development in autoimmune diseases: A meta-analysis","volume":"165","author":"Zintzaras","year":"2005","journal-title":"Arch Intern Med"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-018-3515-2","article-title":"Autoimmune disease-associated non-hodgkin\u2019s lymphoma-a large retrospective study from China","volume":"98","author":"Hu","year":"2019","journal-title":"Ann Hematol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.191027","article-title":"Bidirectional relationship between primary sj\u00f6gren syndrome and non-hodgkin lymphoma: A nationwide Taiwanese population-based study","volume":"47","author":"Wang","year":"2020","journal-title":"J Rheumatol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab939","article-title":"Clinical picture, outcome and predictive factors of lymphoma in primary sj\u00f6gren\u2019s syndrome: results from a harmonized dataset (1981-2021)","volume":"61","author":"Chatzis","year":"2022","journal-title":"Rheumatol (Oxford)"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/art.11144","article-title":"Lymphoma subtypes in patients with rheumatoid arthritis: increased proportion of diffuse large B cell lymphoma","volume":"48","author":"Baecklund","year":"2003","journal-title":"Arthritis Rheum"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2023.100768","article-title":"Risk of cancer for patients with rheumatoid arthritis versus general population: A national claims database cohort study","volume":"35","author":"Beydon","year":"2023","journal-title":"Lancet Reg Health Eur"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.067108","article-title":"A closer look at non-hodgkin\u2019s lymphoma cases in a national swedish systemic lupus erythematosus cohort: A nested case-control study","volume":"66","author":"L\u00f6fstr\u00f6m","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2021-001698","article-title":"Lymphoma complicating rheumatoid arthritis: results from a french case-control study","volume":"7","author":"Kedra","year":"2021","journal-title":"RMD Open"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211623","article-title":"Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis: A european registries collaborative project","volume":"76","author":"Mercer","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-017-0064-4","article-title":"Malignancy incidence, management, and prevention in patients with rheumatoid arthritis","volume":"4","author":"Wilton","year":"2017","journal-title":"Rheumatol Ther"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/1658473","article-title":"Sle and non-hodgkin\u2019s lymphoma: A case series and review of the literature","volume":"2017","author":"Boddu","year":"2017","journal-title":"Case Rep Rheumatol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.034504","article-title":"Non-hodgkin\u2019s lymphoma in systemic lupus erythematosus","volume":"64","author":"Bernatsky","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1097\/bor.0000000000000026","article-title":"Incidence of lymphoma associated with underlying lupus: lessons learned from observational studies","volume":"26","author":"BiChile","year":"2014","journal-title":"Curr Opin Rheumatol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-016-8885-8","article-title":"Correlation between systemic lupus erythematosus and Malignancies: A cross-sectional population-based study","volume":"65","author":"Azrielant","year":"2017","journal-title":"Immunol Res"},{"key":"B54","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1093\/jnci\/djj004","article-title":"Autoimmune and chronic inflammatory disorders and risk of non-hodgkin lymphoma by subtype","volume":"98","author":"Smedby","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwu290","article-title":"Associations of non-hodgkin lymphoma (Nhl) risk with autoimmune conditions according to putative nhl loci","volume":"181","author":"Wang","year":"2015","journal-title":"Am J Epidemiol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3390\/medsci9010005","article-title":"Epidemiology of non-hodgkin\u2019s lymphoma","volume":"9","author":"Thandra","year":"2021","journal-title":"Med Sci (Basel)"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.25680","article-title":"Non-hodgkin lymphoma and autoimmunity: does gender matter","volume":"129","author":"Ansell","year":"2011","journal-title":"Int J Cancer"},{"key":"B58","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.semcancer.2013.12.001","article-title":"Lymphoma\u00a0development in patients with autoimmune and inflammatory disorders\u2013what are the driving forces","volume":"24","author":"Baecklund","year":"2014","journal-title":"Semin Cancer Biol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2010.11.001","article-title":"Excess of autoimmune and chronic inflammatory disorders in patients with lymphoma compared with all cancer patients: A cancer registry-based analysis in the south of the Netherlands","volume":"10","author":"van de Schans","year":"2011","journal-title":"Autoimmun Rev"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2018.1","article-title":"B cells in the pathogenesis of primary sj\u00f6gren syndrome","volume":"14","author":"Nocturne","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2012.11.004","article-title":"Lymphocyte transformation and\u00a0autoimmune disorders","volume":"12","author":"Tarella","year":"2013","journal-title":"Autoimmun Rev"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12684","article-title":"The aetiology of B-cell lymphoid Malignancies with a focus on chronic inflammation and infections","volume":"282","author":"Smedby","year":"2017","journal-title":"J Intern Med"},{"key":"B63","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s12016-018-8721-0","article-title":"Regulatory T cell plasticity and stability and autoimmune diseases","volume":"58","author":"Qiu","year":"2020","journal-title":"Clin Rev Allergy Immunol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2021.09.059","article-title":"Cyclooxygenases and prostaglandins in tumor immunology and microenvironment of gastrointestinal cancer","volume":"161","author":"Wang","year":"2021","journal-title":"Gastroenterology"},{"key":"B65","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1093\/intimm\/dxz021","article-title":"Molecular mechanisms underlying prostaglandin E2-exacerbated inflammation and immune diseases","volume":"31","author":"Tsuge","year":"2019","journal-title":"Int Immunol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-021-00605-2","article-title":"Epithelial-immune cell interplay in primary sj\u00f6gren syndrome salivary gland pathogenesis","volume":"17","author":"Verstappen","year":"2021","journal-title":"Nat Rev Rheumatol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-08-176057","article-title":"A critical role of tak1 in B-cell receptor-mediated nuclear factor kappab activation","volume":"113","author":"Schuman","year":"2009","journal-title":"Blood"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1038\/nature07968","article-title":"Mutations of multiple genes cause deregulation of nf-kappab in diffuse large B-cell lymphoma","volume":"459","author":"Compagno","year":"2009","journal-title":"Nature"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.2147\/cmar.S260583","article-title":"The anti-apoptotic role of ebv-lmp1 in lymphoma cells","volume":"12","author":"Zeng","year":"2020","journal-title":"Cancer Manag Res"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00111","article-title":"Epstein-barr virus and human papillomaviruses interactions and their roles in the initiation of epithelial-mesenchymal transition and cancer progression","volume":"8","author":"Cyprian","year":"2018","journal-title":"Front Oncol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.3390\/ijms23042193","article-title":"Roles and regulation of bcl-xl in hematological Malignancies","volume":"23","author":"Morales-Mart\u00ednez","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.4.1743","article-title":"The nf-kappa B cascade is important in bcl-xl expression and for the anti-apoptotic effects of the cd28 receptor in primary human cd4+ Lymphocytes","volume":"165","author":"Khoshnan","year":"2000","journal-title":"J Immunol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2015.00051","article-title":"The link between autoimmunity and lymphoma: does notch signaling play a contributing role","volume":"5","author":"Kuksin","year":"2015","journal-title":"Front Oncol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2021.155650","article-title":"Emerging roles for il-6 family cytokines as positive and negative regulators of ectopic lymphoid structures","volume":"146","author":"Hill","year":"2021","journal-title":"Cytokine"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209217","article-title":"Ectopic expression of cxcl13, baff, april and lt-B Is associated with artery tertiary lymphoid organs in giant cell arteritis","volume":"76","author":"Ciccia","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B76","doi-asserted-by":"publisher","first-page":"eabf9419","DOI":"10.1126\/science.abf9419","article-title":"Tertiary lymphoid structures in cancer","volume":"375","author":"Schumacher","year":"2022","journal-title":"Science"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00430","article-title":"Ectopic lymphoid structures: powerhouse of autoimmunity","volume":"7","author":"Corsiero","year":"2016","journal-title":"Front Immunol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1443455","article-title":"The role of cytokines from salivary gland epithelial cells in the immunopathology of sj\u00f6gren\u2019s syndrome","volume":"15","author":"Dong","year":"2024","journal-title":"Front Immunol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1186\/ar68","article-title":"Clonal expansion is a characteristic feature of the B-cell repetoire of patients with rheumatoid arthritis","volume":"2","author":"Itoh","year":"2000","journal-title":"Arthritis Res"},{"key":"B80","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s13075-015-0688-0","article-title":"Ectopic lymphoid neogenesis is strongly associated with activation of the il-23 pathway in rheumatoid synovitis","volume":"17","author":"Ca\u00f1ete","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-024-00994-x","article-title":"The regulation and differentiation of regulatory T cells and their dysfunction in autoimmune diseases","volume":"24","author":"Sumida","year":"2024","journal-title":"Nat Rev Immunol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-020711-074934","article-title":"Immune regulatory function of B cells","volume":"30","author":"Mauri","year":"2012","journal-title":"Annu Rev Immunol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2013.04.003","article-title":"The baff\/april system: emerging functions beyond B cell biology and autoimmunity","volume":"24","author":"Vincent","year":"2013","journal-title":"Cytokine Growth Factor Rev"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1221528","article-title":"The off-target effects of aid in carcinogenesis","volume":"14","author":"Jiao","year":"2023","journal-title":"Front Immunol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1159\/000082106","article-title":"The baff\/april system: an important player in systemic rheumatic diseases","volume":"8","author":"Mackay","year":"2005","journal-title":"Curr Dir Autoimmun"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2004.06.041","article-title":"The baff\/april system: life beyond B lymphocytes","volume":"42","author":"Ng","year":"2005","journal-title":"Mol Immunol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/s1044-579x(02)00017-2","article-title":"The biological role of the fas\/fasl system during tumor formation and progression","volume":"12","author":"Reichmann","year":"2002","journal-title":"Semin Cancer Biol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2025.1561102","article-title":"Fas mediates apoptosis, inflammation, and treatment of pathogen infection","volume":"15","author":"Hu","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00403","article-title":"Dual role of fas\/fasl-mediated signal in peripheral immune tolerance","volume":"8","author":"Yamada","year":"2017","journal-title":"Front Immunol"},{"key":"B90","article-title":"Abnormal fas and fas ligand expression of lymphocytes in patients with sle","volume":"54","author":"Suzuki","year":"1996","journal-title":"Nihon Rinsho"},{"key":"B91","doi-asserted-by":"publisher","first-page":"eadk4898","DOI":"10.1126\/science.adk4898","article-title":"A metabolic dependency of ebv can be targeted to hinder B cell transformation","volume":"385","author":"M\u00fcller-Durovic","year":"2024","journal-title":"Science"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-21-3408","article-title":"Facts and hopes in the relationship of ebv with cancer immunity and immunotherapy","volume":"28","author":"Zhang","year":"2022","journal-title":"Clin Cancer Res"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2025.189421","article-title":"From infection to immune exhaustion: the epstein-barr virus and its contribution to immunosenescence","volume":"1880","author":"Hu","year":"2025","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-014-0046-x","article-title":"The tumor marker fascin is induced by the epstein-barr virus-encoded oncoprotein lmp1 via nf-Kb in lymphocytes and contributes to their invasive migration","volume":"12","author":"Mohr","year":"2014","journal-title":"Cell Commun Signal"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-44455-w","article-title":"Epstein-barr virus-driven B cell lymphoma mediated by a direct lmp1-traf6 complex","volume":"15","author":"Giehler","year":"2024","journal-title":"Nat Commun"},{"key":"B96","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.immuni.2024.11.023","article-title":"Hyperreactive B cells instruct their elimination by T cells to curb autoinflammation and lymphomagenesis","volume":"58","author":"Diehl","year":"2025","journal-title":"Immunity"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-023-00720-1","article-title":"Pathogenesis of autoimmune disease","volume":"19","author":"Pisetsky","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/s12016-022-08930-4","article-title":"Systemic sclerosis association with Malignancy","volume":"63","author":"Lepri","year":"2022","journal-title":"Clin Rev Allergy Immunol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0b013e32834a5081","article-title":"Cancer and systemic sclerosis: novel insights into pathogenesis and clinical implications","volume":"23","author":"Shah","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00979","article-title":"The roles of tif1\u03b3 in cancer","volume":"9","author":"Yu","year":"2019","journal-title":"Front Oncol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-022-06166-3","article-title":"Clinical value of cancer-associated myositis-specific antibodies, anti-transcriptional intermediary factor 1-\u0393, and anti-nuclear matrix protein 2 antibodies in a retrospective cohort of dermatomyositis\/polymyositis in a Japanese community hospital","volume":"41","author":"Suga","year":"2022","journal-title":"Clin Rheumatol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2024.101936","article-title":"B cell activation and autoantibody production in autoimmune diseases","volume":"38","author":"Sun","year":"2024","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.actbio.2021.10.024","article-title":"Nanomedicines in B cell-targeting therapies","volume":"137","author":"Wang","year":"2022","journal-title":"Acta Biomater"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/s0092-8674(00)00078-7","article-title":"Class switch recombination and hypermutation require activation-induced cytidine deaminase (Aid), a potential rna editing enzyme","volume":"102","author":"Muramatsu","year":"2000","journal-title":"Cell"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-020-03348-x","article-title":"Activation-induced cytidine deaminase: in sickness and in health","volume":"146","author":"Rios","year":"2020","journal-title":"J Cancer Res Clin Oncol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1080\/08916930701510673","article-title":"Complement deficiencies and systemic lupus erythematosus","volume":"40","author":"Truedsson","year":"2007","journal-title":"Autoimmunity"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00811","article-title":"Understanding fc receptor involvement in inflammatory diseases: from mechanisms to new therapeutic tools","volume":"10","author":"Ben Mkaddem","year":"2019","journal-title":"Front Immunol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2016.07.035","article-title":"Fc-gamma receptors: attractive targets for autoimmune drug discovery searching for intelligent therapeutic designs","volume":"15","author":"Bosques","year":"2016","journal-title":"Autoimmun Rev"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1007\/s12272-025-01532-6","article-title":"Tumor microenvironment regulation by reactive oxygen species-mediated inflammasome activation","volume":"48","author":"Jang","year":"2025","journal-title":"Arch Pharm Res"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-023-00786-x","article-title":"The immunoregulatory roles of non-haematopoietic cells in the kidney","volume":"20","author":"Tsokos","year":"2024","journal-title":"Nat Rev Nephrol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/3128933","article-title":"Tumor-associated inflammation: the tumor-promoting immunity in the early stages of tumorigenesis","volume":"2022","author":"Bi","year":"2022","journal-title":"J Immunol Res"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2019.102392","article-title":"An overview of autoantibodies in rheumatoid arthritis","volume":"110","author":"van Delft","year":"2020","journal-title":"J Autoimmun"},{"key":"B113","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/bor.0000000000000356","article-title":"Anticitrullinated protein antibodies: origin and role in the pathogenesis of rheumatoid arthritis","volume":"29","author":"England","year":"2017","journal-title":"Curr Opin Rheumatol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12865-024-00646-8","article-title":"Transcriptomics explores potential mechanisms for the development of primary sjogren\u2019s syndrome to diffuse large B-cell lymphoma in B cells","volume":"25","author":"Xu","year":"2024","journal-title":"BMC Immunol"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1036239","article-title":"Exploring the molecular mechanisms and shared gene signatures between rheumatoid arthritis and diffuse large B cell lymphoma","volume":"13","author":"Li","year":"2022","journal-title":"Front Immunol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1177\/09612033221114578","article-title":"Exploration of the molecular mechanisms, shared gene signatures, and micrornas between systemic lupus erythematosus and diffuse large B cell lymphoma by bioinformatics analysis","volume":"31","author":"Peng","year":"2022","journal-title":"Lupus"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-019-00733-8","article-title":"The pathogenicity of th17 cells in autoimmune diseases","volume":"41","author":"Yasuda","year":"2019","journal-title":"Semin Immunopathol"},{"key":"B118","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.gene.2017.01.016","article-title":"Interluekin-17a (Il17a)","volume":"614","author":"Chen","year":"2017","journal-title":"Gene"},{"key":"B119","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.3390\/ijms22052719","article-title":"The role of tumor necrosis factor alpha (Tnf-A) in autoimmune disease and current tnf-A Inhibitors in therapeutics","volume":"22","author":"Jang","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2012.10.014","article-title":"Tumor necrosis factor","volume":"328","author":"Chu","year":"2013","journal-title":"Cancer Lett"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2014.07.004","article-title":"Autoantibodies to estrogen receptors and their involvement in autoimmune diseases and cancer","author":"Ortona","year":"2014","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnac017","article-title":"Estrogen receptor signaling in the immune system","volume":"44","author":"Chakraborty","year":"2023","journal-title":"Endocr Rev"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2011.62","article-title":"Susceptibility of patients with rheumatic diseases to B-cell non-hodgkin lymphoma","volume":"7","author":"Dias","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"B124","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.cell.2007.06.033","article-title":"Multistep pathogenesis of autoimmune disease","volume":"130","author":"Goodnow","year":"2007","journal-title":"Cell"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2008.02029.x","article-title":"Autoimmune and inflammatory disorders and risk of Malignant lymphomas\u2013an update","volume":"264","author":"Smedby","year":"2008","journal-title":"J Intern Med"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.Epi-06-0300","article-title":"Malignant lymphomas in autoimmunity and inflammation: A review of risks, risk factors, and lymphoma characteristics","volume":"15","author":"Smedby","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2525","article-title":"Rheumatoid arthritis and lymphoma: incidence, pathogenesis, biology, and outcome","volume":"36","author":"Klein","year":"2018","journal-title":"Hematol Oncol"},{"key":"B128","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/art.21675","article-title":"Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis","volume":"54","author":"Baecklund","year":"2006","journal-title":"Arthritis Rheum"},{"key":"B129","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2174\/1573395511309010003","article-title":"Possible mechanisms of lymphoma development in sj\u00f6gren\u2019s syndrome","volume":"9","author":"Dong","year":"2013","journal-title":"Curr Immunol Rev"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2013.03.001","article-title":"Clinical features distinguishing lymphoma development in primary sj\u00f6gren\u2019s syndrome\u2013a retrospective cohort study","volume":"43","author":"Risselada","year":"2013","journal-title":"Semin Arthritis Rheum"},{"key":"B131","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jaut.2013.10.002","article-title":"Biomarkers of lymphoma in sj\u00f6gren\u2019s syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study","volume":"51","author":"Quartuccio","year":"2014","journal-title":"J Autoimmun"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2011.04.006","article-title":"Risk, predictors, and clinical characteristics of lymphoma development in primary sj\u00f6gren\u2019s syndrome","volume":"41","author":"Solans-Laqu\u00e9","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.144782","article-title":"Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of Malignant lymphoma in primary sj\u00f6gren\u2019s syndrome","volume":"70","author":"Theander","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1080\/03009742.2019.1696403","article-title":"Population-based study of patients with primary sj\u00f6gren\u2019s syndrome and lymphoma: lymphoma subtypes, clinical characteristics, and gender differences","volume":"49","author":"Vasaitis","year":"2020","journal-title":"Scand J Rheumatol"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.47102\/annals-acadmedsg.2022278","article-title":"Characteristics of anti-transcriptional intermediary factor 1 gamma autoantibody-positive dermatomyositis patients in Singapore","volume":"51","author":"Chua","year":"2022","journal-title":"Ann Acad Med Singap"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-024-08794-8","article-title":"Anti-tif1-\u0393 Antibody-positive dermatomyositis leading to identification of diffuse large B-cell lymphoma","volume":"39","author":"Otsuki","year":"2024","journal-title":"J Gen Intern Med"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.101144","article-title":"Malignancies in italian patients with systemic sclerosis positive for anti-rna polymerase iii antibodies","volume":"38","author":"Airo","year":"2011","journal-title":"J Rheumatol"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-022-08944-y","article-title":"Autoantibodies and cancer association: the case of systemic sclerosis and dermatomyositis","volume":"63","author":"Fiorentino","year":"2022","journal-title":"Clin Rev Allergy Immunol"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2024-004492","article-title":"Autoantibodies, cutaneous subset and immunosuppressants contribute to the cancer risk in systemic sclerosis","volume":"10","author":"Tonutti","year":"2024","journal-title":"RMD Open"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2011.04.010","article-title":"Anti-tnf therapy: safety aspects of taking the risk","volume":"10","author":"Rosenblum","year":"2011","journal-title":"Autoimmun Rev"},{"key":"B141","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1136\/annrheumdis-2016-209389","article-title":"Risk of lymphoma in patients exposed to antitumour necrosis factor therapy: results from the british society for rheumatology biologics register for rheumatoid arthritis","volume":"76","author":"Mercer","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1002\/art.21029","article-title":"An international cohort study of cancer in systemic lupus erythematosus","volume":"52","author":"Bernatsky","year":"2005","journal-title":"Arthritis Rheum"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2025.101225","article-title":"Methotrexate resistance and its regulatory mechanisms in pediatric tumors and beyond","volume":"81","author":"Nie","year":"2025","journal-title":"Drug Resist Update"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1172\/jci2676","article-title":"Immunosuppressive properties of methotrexate: apoptosis and clonal deletion of activated peripheral T cells","volume":"102","author":"Genestier","year":"1998","journal-title":"J Clin Invest"},{"key":"B145","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s13075-024-03403-9","article-title":"Low Dose Methotrexate Impaired T Cell Transmigration through down-Regulating Cxcr4 Expression in Rheumatoid Arthritis (Ra)","volume":"26","author":"Ding","year":"2024","journal-title":"Arthritis Res Ther"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/lgfbtq","article-title":"Involvement of epstein-barr virus in the development and spontaneous regression of methotrexate-associated lymphoproliferative disorder in patients with rheumatoid arthritis","volume":"40","author":"Kitamura","year":"2022","journal-title":"Clin Exp Rheumatol"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1111\/cas.15894","article-title":"Lymphoproliferative disorder risk after methotrexate treatment for rheumatoid arthritis","volume":"114","author":"Tanaka","year":"2023","journal-title":"Cancer Sci"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22306","article-title":"Association of higher methotrexate dose with lymphoproliferative disease onset in rheumatoid arthritis patients","volume":"66","author":"Kameda","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1097\/pas.0000000000001271","article-title":"Methotrexate-associated lymphoproliferative disorders in patients with rheumatoid arthritis: clinicopathologic features and prognostic factors","volume":"43","author":"Kurita","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1111\/cas.13249","article-title":"Clinicopathological analysis of methotrexate-associated lymphoproliferative disorders: comparison of diffuse large B-cell lymphoma and classical hodgkin lymphoma types","volume":"108","author":"Gion","year":"2017","journal-title":"Cancer Sci"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.30328","article-title":"Epstein-barr virus-positive lymphoma in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine","volume":"122","author":"Dayharsh","year":"2002","journal-title":"Gastroenterology"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.16071","article-title":"Association between use of thiopurines or tumor necrosis factor antagonists alone or in combination and risk of lymphoma in patients with inflammatory bowel disease","volume":"318","author":"Lemaitre","year":"2017","journal-title":"Jama"},{"key":"B153","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.3390\/medicina60071156","article-title":"Anti-tnf alpha and risk of lymphoma in rheumatoid arthritis: A systematic review and meta-analysis","volume":"60","author":"Imam","year":"2024","journal-title":"Med (Kaunas)"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31407","article-title":"Tumor necrosis factor-alpha inhibitors and risk of non-hodgkin lymphoma in a cohort of adults with rheumatologic conditions","volume":"143","author":"Calip","year":"2018","journal-title":"Int J Cancer"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1002\/art.40654","article-title":"Prevalence and characteristics of persistent clonal T cell large granular lymphocyte expansions in rheumatoid arthritis: A comprehensive analysis of 529 patients","volume":"70","author":"Schwaneck","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"B156","doi-asserted-by":"publisher","first-page":"e17890","DOI":"10.1371\/journal.pone.0017890","article-title":"Infliximab induces clonal expansion of \u0393\u03b4-T cells in crohn\u2019s disease: A predictor of lymphoma risk","volume":"6","author":"Kelsen","year":"2011","journal-title":"PloS One"},{"key":"B157","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1186\/ar4686","article-title":"The value of glucocorticoid co-therapy in different rheumatic diseases\u2013positive and adverse effects","author":"van der Goes","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.Capr-20-0161","article-title":"Long-term glucocorticoid use and cancer risk: A population-based cohort study in South Korea","volume":"13","author":"Oh","year":"2020","journal-title":"Cancer Prev Res (Phila)"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1002\/art.40017","article-title":"Rheumatoid arthritis and risk of Malignant lymphoma: is the risk still increased","volume":"69","author":"Hellgren","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v99.11.3909","article-title":"Lymphomas in rheumatoid arthritis patients treated with methotrexate: A 3-year prospective study in France","volume":"99","author":"Mariette","year":"2002","journal-title":"Blood"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1111\/apt.16050","article-title":"Systematic review with meta-analysis: comparative risk of lymphoma with anti-tumour necrosis factor agents and\/or thiopurines in patients with inflammatory bowel disease","volume":"52","author":"Chupin","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"B162","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.39480","article-title":"2015 american college of rheumatology guideline for the treatment of rheumatoid arthritis","volume":"68","author":"Singh","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1016\/j.envpol.2023.123097","article-title":"Long-term exposure to ambient air pollution and risk of leukemia and lymphoma in a pooled european cohort","volume":"343","author":"Taj","year":"2024","journal-title":"Environ pollut"},{"key":"B164","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1136\/ard.2008.096487","article-title":"Impact of smoking as a risk factor for developing rheumatoid arthritis: A meta-analysis of observational studies","volume":"69","author":"Sugiyama","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1221125","article-title":"Modifiable risk factors linked\u00a0to\u00a0the development of rheumatoid arthritis: evidence, immunological mechanisms and prevention","volume":"14","author":"Maisha","year":"2023","journal-title":"Front Immunol"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.35095","article-title":"Occupational exposure to benzene and risk of non-hodgkin lymphoma in an extended follow-up of two population-based prospective cohorts of chinese men and women","volume":"155","author":"Bassig","year":"2024","journal-title":"Int J Cancer"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1016\/s2542-5196(21)00149-2","article-title":"Benzene exposure and non-hodgkin lymphoma: A systematic review and meta-analysis of human studies","volume":"5","author":"Rana","year":"2021","journal-title":"Lancet Planet Health"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1136\/oemed-2020-106517","article-title":"Benzene-associated immunosuppression and chronic inflammation in humans: A systematic review","volume":"78","author":"Guo","year":"2020","journal-title":"Occup Environ Med"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.33740","article-title":"Occupational insecticide exposure and risk of non-hodgkin lymphoma: A pooled case-control study from the interlymph consortium","volume":"149","author":"De Roos","year":"2021","journal-title":"Int J Cancer"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-024-01167-9","article-title":"Epstein-barr virus as a potentiator of autoimmune diseases","volume":"20","author":"Robinson","year":"2024","journal-title":"Nat Rev Rheumatol"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.587380","article-title":"Epstein-barr virus and systemic autoimmune diseases","volume":"11","author":"Houen","year":"2020","journal-title":"Front Immunol"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.2014.930346","article-title":"Should we target patients with autoimmune diseases for human papillomavirus vaccine uptake","volume":"13","author":"Feldman","year":"2014","journal-title":"Expert Rev Vaccines"},{"key":"B173","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1159\/000535592","article-title":"Retrospective investigation of human papillomavirus cervical infection and lymphoma incidence: A clinical and pathological evaluation","volume":"89","author":"Gardella","year":"2024","journal-title":"Gynecol Obstet Invest"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-04-537498","article-title":"Familial predisposition and genetic risk factors for lymphoma","volume":"126","author":"Cerhan","year":"2015","journal-title":"Blood"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrrev.2021.108386","article-title":"Genetic predisposition to lymphomas: overview of rare syndromes and inherited familial variants","volume":"788","author":"Szmyd","year":"2021","journal-title":"Mutat Res Rev Mutat Res"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12911","article-title":"The role of hla variation in lymphoma aetiology and survival","volume":"286","author":"Zhong","year":"2019","journal-title":"J Intern Med"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2013.842982","article-title":"Genetic polymorphism of tumor necrosis factor promoter region and susceptibility to develop hodgkin lymphoma in a mexican population","volume":"55","author":"Torres-Esp\u00edndola","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-06-4752","article-title":"Immune mechanisms in non-hodgkin lymphoma: joint effects of the tnf G308a and il10 T3575a polymorphisms with non-hodgkin lymphoma risk factors","volume":"67","author":"Wang","year":"2007","journal-title":"Cancer Res"},{"key":"B179","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/s1470-2045(05)70434-4","article-title":"Genetic variation in tnf and il10 and risk of non-hodgkin lymphoma: A report from the interlymph consortium","volume":"7","author":"Rothman","year":"2006","journal-title":"Lancet Oncol"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdl467","article-title":"Influence of rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone on serologic parameters and clinical course in lymphoma patients with autoimmune diseases","volume":"18","author":"W\u00f6hrer","year":"2007","journal-title":"Ann Oncol"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.110077","article-title":"Treatment of mucosa-associated lymphoid tissue lymphoma in sjogren\u2019s syndrome: A retrospective clinical study","volume":"38","author":"Pollard","year":"2011","journal-title":"J Rheumatol"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1016\/s2665-9913(24)00198-x","article-title":"Treatment modalities of marginal zone lymphoma and overall survival, haematological response, and underlying sj\u00f6gren\u2019s disease activity: A multicentre, retrospective, observational study","volume":"6","author":"Rocca","year":"2024","journal-title":"Lancet Rheumatol"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/8631061","article-title":"Autoimmune\/inflammatory arthritis associated lymphomas: who is at risk","volume":"2016","author":"Yadlapati","year":"2016","journal-title":"BioMed Res Int"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2015.33","article-title":"Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis","volume":"11","author":"Mohan","year":"2015","journal-title":"Nat Rev Nephrol"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad474","article-title":"Unintended consequences: risk of opportunistic infections associated with long-term glucocorticoid therapies in adults","volume":"78","author":"Chastain","year":"2024","journal-title":"Clin Infect Dis"},{"key":"B186","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41392-024-01952-8","article-title":"Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders","volume":"9","author":"Song","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.3109\/14397595.2013.878016","article-title":"Clinical characteristics and incidence of methotrexate-related lymphoproliferative disorders of patients with rheumatoid arthritis","volume":"24","author":"Yoshida","year":"2014","journal-title":"Mod Rheumatol"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.2012.685650","article-title":"Tyrosine kinase inhibitors as potential drugs for B-cell lymphoid Malignancies and autoimmune disorders","volume":"21","author":"Robak","year":"2012","journal-title":"Expert Opin Investig Drugs"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2012.05.014","article-title":"B cells in sj\u00f6gren\u2019s syndrome: from pathophysiology to diagnosis and treatment","volume":"39","author":"Cornec","year":"2012","journal-title":"J Autoimmun"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2025.103859","article-title":"Chimeric antigen receptor cell therapy: A revolutionary approach transforming cancer treatment to autoimmune disease therapy","volume":"24","author":"Wen","year":"2025","journal-title":"Autoimmun Rev"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2024.103687","article-title":"Harnessing the potential of car-T cell in lupus treatment: from theory to practice","volume":"23","author":"Alsuliman","year":"2024","journal-title":"Autoimmun Rev"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2019.12.025","article-title":"Anti-cd20-mediated B-cell depletion in autoimmune diseases: successes, failures and future perspectives","volume":"97","author":"Crickx","year":"2020","journal-title":"Kidney Int"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1454747","article-title":"Cutting-edge approaches to B-cell depletion in autoimmune diseases","volume":"15","author":"Robinson","year":"2024","journal-title":"Front Immunol"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1080\/17843286.2018.1521904","article-title":"Rituximab in systemic autoimmune rheumatic diseases: indications and practical use","volume":"74","author":"Berghen","year":"2019","journal-title":"Acta Clin Belg"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2018.03.062","article-title":"The development of bruton\u2019s tyrosine kinase (Btk) inhibitors from 2012 to 2017: A mini-review","volume":"151","author":"Liang","year":"2018","journal-title":"Eur J Med Chem"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02602","article-title":"Autologous hematopoietic stem cell transplantation for autoimmune diseases: from mechanistic insights to biomarkers","volume":"9","author":"Malmegrim","year":"2018","journal-title":"Front Immunol"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1007\/s12328-021-01389-4","article-title":"Long-term endoscopic remission in crohn\u2019s disease after allogeneic hematopoietic stem cell transplantation for diffuse large B cell lymphoma: case report and literature review","volume":"14","author":"Inomata","year":"2021","journal-title":"Clin J Gastroenterol"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1136\/ard.60.2.173b","article-title":"Haematopoietic stem cell transplantation (Hsct) in a patient with sj\u00f6gren\u2019s syndrome and lung malt lymphoma cured lymphoma not the autoimmune disease","volume":"60","author":"Ferraccioli","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1701312","article-title":"Autologous pbpct in a patient with lymphoma and sj\u00f6gren\u2019s syndrome: complete remission of lymphoma without control of the autoimmune disease","volume":"22","author":"R\u00f6sler","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"B200","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/1756-185x.13231","article-title":"Clinical features and outcome of lymphoma patients with pre-existing autoimmune diseases","volume":"21","author":"Shih","year":"2018","journal-title":"Int J Rheum Dis"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1719391\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T06:45:32Z","timestamp":1767681932000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1719391\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,6]]},"references-count":200,"alternative-id":["10.3389\/fimmu.2025.1719391"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1719391","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,6]]},"article-number":"1719391"}}